The Biden Administration will make over 170 million doses of the bivalent COVID-19 vaccine booster available to Americans for free at pharmacies, doctor’s offices, health centers, and state and local health departments, the White House announced today. Americans can find local sites administering the vaccine booster here. Once pre-ordered doses are delivered, officials expect over 90% of Americans to have a site within five miles of where they live.

According to the Administration, the Federal Emergency Management Agency will continue to reimburse 90% of eligible costs to set up vaccination sites. The Centers for Medicare & Medicaid Services plans to share information on the new boosters with Medicare enrollees in the coming weeks, and help nursing homes plan to vaccinate residents and staff. In addition, the Department of Health and Human Services will launch a paid media campaign and work with community groups to encourage vaccination.

Among other actions, the Administration plans to purchase 100 million additional at-home COVID-19 tests for the Strategic National Stockpile; add more test-to-treat sites; and eventually transition procurement and distribution of COVID-19 vaccines, tests and treatments to the commercial market.

Related News Articles

Headline
Health care providers who treat uninsured or underinsured patients with commercially procured bebtelovimab, a COVID-19 monoclonal antibody therapy for…
Headline
Moderna Friday submitted its request that the Food and Drug Administration authorize for emergency use its bivalent COVID-19 vaccine for children and…
Headline
AHA will co-host a Sept. 27 Facebook Live event with AdventHealth on the importance of getting children vaccinated and boosted against COVID-19, which will…
Headline
Insured and uninsured Americans can receive the new bivalent Pfizer or Moderna COVID-19 booster and other COVID-19 vaccines at no cost as long as the federal…
Headline
The Centers for Disease Control and Prevention last week recommended Pfizer’s updated COVID-19 vaccine booster for Americans aged 12 and older and Moderna…
Headline
The Food and Drug Administration yesterday announced it has amended the emergency use authorizations for Pfizer’s and Moderna’s COVID-19 vaccines to…